These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Yu D, Zhang X, Liu J, Yuan P, Tan W, Guo Y, Sun T, Zhao D, Yang M, Liu J, Xu B, Lin D. Clin Cancer Res; 2008 May 01; 14(9):2878-86. PubMed ID: 18451256 [Abstract] [Full Text] [Related]
11. Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. Wei HB, Lu XS, Shang LH, Xu G, Hu J, Che DH, Liu F, Wu Y, Zhang GM, Yu Y. Arch Med Res; 2011 Jul 01; 42(5):412-20. PubMed ID: 21827803 [Abstract] [Full Text] [Related]
19. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Saadat M, Ansari-Lari M. Breast Cancer Res Treat; 2009 May 01; 115(1):137-44. PubMed ID: 18481169 [Abstract] [Full Text] [Related]
20. Association of an ERCC1 polymorphism with adult-onset glioma. Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. Cancer Epidemiol Biomarkers Prev; 2000 Aug 01; 9(8):843-7. PubMed ID: 10952103 [Abstract] [Full Text] [Related] Page: [Next] [New Search]